Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-02-26
2011-10-25
Dentz, Bernard (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S337000, C546S282700, C549S023000, C549S365000, C549S408000, C549S410000
Reexamination Certificate
active
08044097
ABSTRACT:
The invention relates to novel chroman derivatives, stereoisomers and pharmaceutically acceptable salts of Formula Iwherein the substituents are as defined in the specification. They are useful in the treatment of disorders mediated by lipoxygenase, such as immune diseases, respiratory diseases and cardiovascular diseases, as well as in the treatment of neurodegenerative disorders and/or mitochondria) disorders. They are also useful in the manufacture of pharmaceutical formulations for the treatment of such conditions.
REFERENCES:
patent: 3574627 (1971-04-01), Stern at al.
patent: 3801603 (1974-04-01), Hartmann at al.
patent: 4360532 (1982-11-01), Sundeen
patent: 4452801 (1984-06-01), Sundeen
patent: 4511685 (1985-04-01), Nissen et al.
patent: 4515975 (1985-05-01), Vogel et al.
patent: 4645845 (1987-02-01), Gehrken et al.
patent: 4716238 (1987-12-01), Timár et al.
patent: 4728650 (1988-03-01), Eziri et al.
patent: 4780469 (1988-10-01), Toda et al.
patent: 4814346 (1989-03-01), Albert et al.
patent: 4877810 (1989-10-01), Mickle et al.
patent: 4950684 (1990-08-01), Koszyk et al.
patent: 5015661 (1991-05-01), Walser
patent: 5059609 (1991-10-01), Eggler et al.
patent: 5082849 (1992-01-01), Huang et al.
patent: 5093353 (1992-03-01), Koszyk et al.
patent: 5099012 (1992-03-01), Wu et al.
patent: 5132310 (1992-07-01), Walser
patent: 5155130 (1992-10-01), Stanton et al.
patent: 5250547 (1993-10-01), Lochead et al.
patent: 5260294 (1993-11-01), Walser
patent: 5290797 (1994-03-01), Le Baut et al.
patent: 5326771 (1994-07-01), Heine et al.
patent: 5350751 (1994-09-01), Wagner et al.
patent: 5385931 (1995-01-01), Bigg et al.
patent: 5393775 (1995-02-01), Le Baut et al.
patent: 5395834 (1995-03-01), Le Baut et al.
patent: 5424321 (1995-06-01), Hellberg et al.
patent: 5484810 (1996-01-01), Grisar et al.
patent: 5500444 (1996-03-01), Grisar et al.
patent: 5534536 (1996-07-01), Ohuchida et al.
patent: 5541199 (1996-07-01), Mewshaw
patent: 5591772 (1997-01-01), Lane et al.
patent: 5607966 (1997-03-01), Hellberg et al.
patent: 5646149 (1997-07-01), Hellberg et al.
patent: 5663294 (1997-09-01), Colman et al.
patent: 5670667 (1997-09-01), Mewshaw
patent: 5672710 (1997-09-01), Beard et al.
patent: 5684039 (1997-11-01), Mewshaw
patent: 5719180 (1998-02-01), Shudo et al.
patent: 5747528 (1998-05-01), Trivedi
patent: 5750544 (1998-05-01), Ohuchida et al.
patent: 5756521 (1998-05-01), Mewshaw
patent: 5811438 (1998-09-01), Hellberg et al.
patent: 5821130 (1998-10-01), Baldwin et al.
patent: 5821264 (1998-10-01), Lane et al.
patent: 5846988 (1998-12-01), Hellberg
patent: 5849755 (1998-12-01), Englert et al.
patent: 5874461 (1999-02-01), de Chaffoy de Courcelles et al.
patent: 5925673 (1999-07-01), Hellberg et al.
patent: 5981530 (1999-11-01), Ogata et al.
patent: 5981572 (1999-11-01), Ellis et al.
patent: 5990142 (1999-11-01), Carganico et al.
patent: 6034256 (2000-03-01), Carter et al.
patent: 6133277 (2000-10-01), Wingerinck et al.
patent: 6150402 (2000-11-01), Wechter et al.
patent: 6222051 (2001-04-01), Lee et al.
patent: 6235774 (2001-05-01), Fahrig et al.
patent: 6242479 (2001-06-01), Wechter
patent: 6331532 (2001-12-01), Murphy et al.
patent: 6331561 (2001-12-01), Fahrig et al.
patent: 6342602 (2002-01-01), Teng et al.
patent: 6387899 (2002-05-01), Berg et al.
patent: 6410589 (2002-06-01), Wechter
patent: 6417223 (2002-07-01), Sanders et al.
patent: 6479497 (2002-11-01), Berg et al.
patent: 6498191 (2002-12-01), Ghosh et al.
patent: 6511966 (2003-01-01), Ghosh et al.
patent: 6518250 (2003-02-01), Yoshikawa et al.
patent: 6555575 (2003-04-01), Wechter
patent: 6596745 (2003-07-01), Gall
patent: 6645998 (2003-11-01), Sanders et al.
patent: 7470798 (2008-12-01), Wang et al.
patent: 2001/0018530 (2001-08-01), Fahrig et al.
patent: 2002/0016359 (2002-02-01), Hellberg et al.
patent: 2002/0052342 (2002-05-01), Murphy et al.
patent: 2002/0082292 (2002-06-01), Sahoo et al.
patent: 2002/0127252 (2002-09-01), Kramer et al.
patent: 2003/0069208 (2003-04-01), Murphy et al.
patent: 2003/0100603 (2003-05-01), Beinlich et al.
patent: 2003/0103895 (2003-06-01), Cyr et al.
patent: 2003/0103899 (2003-06-01), Cyr
patent: 2003/0176448 (2003-09-01), Ghosh et al.
patent: 2003/0233002 (2003-12-01), Kanter et al.
patent: 2004/0097433 (2004-05-01), Boddupalli et al.
patent: 2005/0065099 (2005-03-01), Walkinshaw et al.
patent: 3842029 (1990-06-01), None
patent: 0 535 283 (1993-04-01), None
patent: 48092372 (1973-11-01), None
patent: 62292777 (1987-12-01), None
patent: 10-251247 (1998-09-01), None
patent: WO-87/05020 (1987-08-01), None
patent: WO-96/16957 (1996-06-01), None
patent: WO-01/05781 (2001-01-01), None
Christen, S. et al. (Apr. 1997). “γ-Tocopherol Traps Mutagenic Electrophiles Such as NOxand Complements α-Tocopherol: Physiological Implications,”Proc. Natl. Acad. Sci. 94:3217-3222.
Dallaker, F. et al. (1991). “Derivatives of the Vitamin E series.2. Preparation of All-Rac-5-Prenyl-γ-Tocopherol,”Chemiker Zeitung115(10):258-289. (Abstract Only).
Fryer, M.J. (1998). “Vitamin E Status and Neurodegenerative Disease,”Nutritional Neuroscience1:327-351.
Jauslin, M.L. (e-pub. Aug. 15, 2003). “Mitochondria-Targeted Antioxidants protect Friedreich Ataxia Fibroblasts from Endogenous Oxidative Stress More Effectively than Untargeted Antioxidants,”FASEB Journal10.1096/fj.03-240.fje.
Kelso, G.F. et al. (2002). “Prevention of Mitochondrial Oxidative Damage Using Targeted Antioxidants,”Annals of the New York Academy of Sciences959:263-274.
Lang, D. (2002). “Cardiac Hypertrophy and Oxidative Stress: A Leap of Faith or Stark Reality?”Heart87:316-318.
Skinner, W.A. et al. (Jul. 1967). “Structure-Activity Relations in the Vitamin E Series. I. Effects of 5-Methyl Substitution on 6-Hydroxy-2,2,5,7,8-Pentamethylchroman,”Journal of Medicinal Chemistry10(4):657-661.
Smith, R.A.J. et al. (Apr. 29, 2003). “Delivery of Bioactive Molecules to Mitochondria in vivo,”PNAS100(9):5407-5412.
Wolf, H. et al. (1981). “Protektiver Effekt der Antioxidativ Wirksamen Chromanstruktur des Tocopherols Auf die Folgen Stimulierter Arachidonsäure-Freisetzung in der Pulmonalen Strombahn,”Klinsche Wochenschrift59:463-465. (Translation of Abstract Only).
Wolf, H.R.D. et al. (1982). “Experimental and Clinical Results in Shock Lung Treatment with Vitamin E,”Annals of the New York Academy of Sciences393:392-410.
Chen Jian
Wang Bing
Ampere Life Sciences, Inc.
Dentz Bernard
Morrison & Foerster / LLP
LandOfFree
Chroman derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chroman derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chroman derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282362